|
|
|
| Research progress of hybrid particles reinforced aluminum matrix composites |
| GAO Hong-xia, WANG Meng, FAN Jiang-lei, WANG Yan, LI Ying, WU Shen |
| He’nan Key Laboratory of Intelligent Manufacturing of Mechanical Equipment, Zhengzhou University of Light Industry, Zhengzhou 450002, Chinaof Dermatology and Venereology,Coal General Hospital,Beijing 100028,China |
|
|
|
|
Abstract Hybrid particles reinforced aluminum matrix composite has the advantages of maintaining the advantages of all reinforcing phases, the synergistic hybrid effect of multiphase simultaneous enhancement, excellent comprehensive performance, etc., which has become a new research direction of composites at present. The research progress of hybrid particle reinforced aluminum matrix composites was reviewed in terms of hybrid types and main preparation methods. At the same time, corresponding solutions were put forward to the problems of uneven particle distribution, difficult determination of content ratio and interface effect in the current composite preparation process. Finally, the development prospect of hybrid particle reinforced aluminum matrix composite was prospected.
|
|
Received: 30 October 2018
|
|
|
|
[1] Benedet JL, Bender H, Jones H 3rd, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancersFIGO Committee on Gynecologic Oncology[J].Int J Gynaecol Obstet.2000,70(2):209-262
[2] Oehler MK, Wain GV, Brand A. Gynaecological malignancies in pregnancy: a review[J].Aust N Z J Obstet Gynaecol.2003, 43(6):414-420
[3] Sayedur Rahman M, Al-Sibai MH, Rahman J, et al. Ovarian carcinoma associated with pregnancy. A review of9 cases[J]. Acta Obstet Gynecol Scand, 2002, 81(3):260-264.
[4] Machado F, Vegas C, Leon J, et al. Ovarian cancer during pregnancy: analysis of 15 cases[J].Gynecol Oncol.2007, 105(2):446-450
[5] 付晨薇, 杨佳欣, 刘俊涛, 等. 剖宫产术中附件包块手术病例分析[J]. 中华围产医学杂志, 2007, 10(5):336-338.
[6] Behtash N, Karimi Zarchi M, Modares Gilani M, et al. Ovarian carcinoma associated with pregnancy: a clinicopathologic analysis of 23 cases and review of the literature[J].BMC Pregnancy Childbirth.2008, 8:3-
[7] Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature[J].BJOG.2009, 116(4):480-491
[8] Leiserowitz GS, Xing G, Cress R, et al. Adnexal masses in pregnancy: how often are they malignant[J].Gynecol Oncol.2006, 101(2):315-321
[9] Modares Gilani M, Karimi Zarchi M, Behtash N, et al. Preservation of pregnancy in a patient with advanced ovarian caner at 20 weeks of gestation: case report and literature review[J].Int J Gynecol Cancer.2007, 17(5):1140-1143
[10] Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome after in utero exposure to cancer chemotherapy[J].Arch Intern Med.1992, 152(3):573-576
[11] Kwon YS, Mok JE, Lim KT, et al. Ovarian cancer during pregnancy: clinical and pregnancy outcome[J].J Korean Med Sci.2010, 25(2):230-234
[12] Jameel A, Jamil SN. Safety of cytotoxic chemotherapy during pregnancy[J]. J pak Med Assoc, 2007, 57(9):449-452.
[13] Ishioka S, Hayashi T, Endo T, et al. Advanced epithelial ovarian carcinoma during pregnancy[J].Int J Clin Oncol.2007, 12(2):375-378
|
|
|
|
2019, Vol. 29 
